Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A N Phillips

Showing results (161-170 of 234) with videos related to

Pageof 24
Sort By:
American Journal of Respiratory and Critical Care Medicine|September 16, 2000
Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JDO Kirk, J M Gatell, A Mocroft, et al.
HIV Medicine|May 16, 2002
The changing demographics of new HIV diagnoses at a London centre from 1994 to 2000S M Barry, S J Lloyd-Owen, S J Madge, et al.
Lancet (London, England)|July 31, 2007
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort studyA Mocroft, A N Phillips, J Gatell, et al.
The Journal of Infectious Diseases|July 9, 1999
CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus loadV Miller, S Staszewski, C Sabin, et al.
The Journal of Infectious Diseases|May 24, 2000
Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophiliaC A Sabin, H L Devereux, G Clewley, et al.
HIV Medicine|February 20, 2007
Treatment outcomes amongst previously antiretroviral-naïve HIV-infected patients starting lopinavir/ritonavir-containing antiretroviral regimens at the Royal Free HospitalC J Smith, A N Phillips, M S Youle, et al.
Lancet (London, England)|November 9, 2000
AIDS across Europe, 1994-98: the EuroSIDA studyA Mocroft, C Katlama, A M Johnson, et al.
JAMA|April 13, 1994
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study GroupJ D Lundgren, A N Phillips, C Pedersen, et al.
AIDS (London, England)|November 4, 2000
The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral loadV Miller, C A Sabin, A N Phillips, et al.
AIDS (London, England)|May 1, 1993
Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45R0+ cells of the CD4 and CD8 lineagesG Janossy, N Borthwick, R Lomnitzer, et al.
Pageof 24

Showing results (161-170 of 234) with videos related to

Sort By:
Pageof 24
American Journal of Respiratory and Critical Care Medicine|September 16, 2000
Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JDO Kirk, J M Gatell, A Mocroft, et al.
HIV Medicine|May 16, 2002
The changing demographics of new HIV diagnoses at a London centre from 1994 to 2000S M Barry, S J Lloyd-Owen, S J Madge, et al.
Lancet (London, England)|July 31, 2007
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort studyA Mocroft, A N Phillips, J Gatell, et al.
The Journal of Infectious Diseases|July 9, 1999
CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus loadV Miller, S Staszewski, C Sabin, et al.
The Journal of Infectious Diseases|May 24, 2000
Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophiliaC A Sabin, H L Devereux, G Clewley, et al.
HIV Medicine|February 20, 2007
Treatment outcomes amongst previously antiretroviral-naïve HIV-infected patients starting lopinavir/ritonavir-containing antiretroviral regimens at the Royal Free HospitalC J Smith, A N Phillips, M S Youle, et al.
Lancet (London, England)|November 9, 2000
AIDS across Europe, 1994-98: the EuroSIDA studyA Mocroft, C Katlama, A M Johnson, et al.
JAMA|April 13, 1994
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study GroupJ D Lundgren, A N Phillips, C Pedersen, et al.
AIDS (London, England)|November 4, 2000
The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral loadV Miller, C A Sabin, A N Phillips, et al.
AIDS (London, England)|May 1, 1993
Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45R0+ cells of the CD4 and CD8 lineagesG Janossy, N Borthwick, R Lomnitzer, et al.
Pageof 24